CANTAB the World’s Leading Cognitive Assessments
Translational, objective and validated. Gold standard cognitive testing products for researchers.
Accelerating safe and effective pharmaceutical development with increased chances of success.
Detecting cognitive impairment early to maximize the effect of treatments, improve wellbeing and save costs.
Cloud-based cognitive assessments now available for drug developments for multiple therapeutic areas including Alzheimer's disease, autism, Down's syndrome, epilepsy, Huntington's, multiple sclerosis, stroke/cerebrovascular disease, Parkinson's, depression, and traumatic brain injury.